Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
17Biotech, also known as Yiqi Biotech, is a specialized biotechnology company focused on DNA-encoded library (DEL) technology to facilitate small molecule drug discovery. Based in Beijing, the company offers a comprehensive platform for library construction, screening, and lead optimization, catering to global pharmaceutical and biotech clients. Their technology allows for the screening of billions of compounds simultaneously, significantly reducing the time and cost associated with traditional high-throughput screening. 17Biotech's expertise spans various target classes, including challenging proteins like G protein-coupled receptors and protein-protein interactions. The company aims to bridge the gap between chemical space and biological targets through its proprietary encoding and selection methodologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yiqi.